{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:00:26Z","timestamp":1792425626125,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174271"],"award-info":[{"award-number":["82174271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejphar.2025.177353","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T16:45:41Z","timestamp":1739810741000},"page":"177353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Astragaloside IV prevents liver fibrosis by blocking glycolysis-mediated macrophage M1 polarization"],"prefix":"10.1016","volume":"995","author":[{"given":"Yutong","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luojia","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177353_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133543","article-title":"Revealing immune infiltrate characteristics and potential immune-related genes in hepatic fibrosis: based on bioinformatics, transcriptomics and q-PCR experiments","volume":"14","author":"Bai","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177353_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1172\/JCI93562","article-title":"The balancing act of the liver: tissue regeneration versus fibrosis","volume":"128","author":"Cordero-Espinoza","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.177353_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrgastro.2016.97","article-title":"Liver regeneration - mechanisms and models to clinical application","volume":"13","author":"Forbes","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177353_bib4","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1038\/s41467-023-42187-5","article-title":"SUN1\/2 controls macrophage polarization via modulating nuclear size and stiffness","volume":"14","author":"Jiao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177353_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2025.177353_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.177353_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.24272\/j.issn.2095-8137.2024.002","article-title":"Overexpression of wild-type HRAS drives non-alcoholic steatohepatitis to hepatocellular carcinoma in mice","volume":"45","author":"Ling","year":"2024","journal-title":"Zool. Res."},{"key":"10.1016\/j.ejphar.2025.177353_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.apsb.2023.10.023","article-title":"Epigenetic modification in liver fibrosis: promising therapeutic direction with significant challenges ahead","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2025.177353_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.ejphar.2025.177353_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd.2017.170","article-title":"Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease","volume":"16","author":"Mora","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2025.177353_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2025.177353_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.24272\/j.issn.2095-8137.2022.389","article-title":"Depletion of microglia with PLX3397 attenuates MK-801-induced hyperactivity associated with regulating inflammation-related genes in the brain","volume":"44","author":"Ni","year":"2023","journal-title":"Zool. Res."},{"key":"10.1016\/j.ejphar.2025.177353_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejphar.2025.177353_bib14","article-title":"UHPLC-MS\/MS analysis on flavonoids composition in Astragalus membranaceus and their antioxidant activity","volume":"10","author":"Sheng","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.ejphar.2025.177353_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114299","article-title":"Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: an HPLC-TOF\/MS-based untargeted metabolomics study","volume":"183","author":"Song","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177353_bib16","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177353_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg0338","article-title":"Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation","volume":"16","author":"Tadokoro","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.177353_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/284025","article-title":"Preventive effects of a natural anti-inflammatory agent, astragaloside IV, on ischemic acute kidney injury in rats","volume":"2013","author":"Tan","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ejphar.2025.177353_bib19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177353_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9206951","article-title":"The combination of Astragalus membranaceus and angelica sinensis inhibits lung cancer and cachexia through its immunomodulatory function","volume":"2019","author":"Wu","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.ejphar.2025.177353_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.177353_bib22","article-title":"Smart microneedle arrays integrating cell-free therapy and nanocatalysis to treat liver fibrosis","volume":"11","author":"Xu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejphar.2025.177353_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110012","article-title":"An updated role of astragaloside IV in heart failure","volume":"126","author":"Zang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177353_bib24","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.7150\/thno.53749","article-title":"Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2025.177353_bib25","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/ptr.6070","article-title":"Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: regulation on glycolysis through miRNA-34a\/LDHA pathway","volume":"32","author":"Zhang","year":"2018","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2025.177353_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114350","article-title":"Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C\/3L and Nrf2\/HO-1 pathways","volume":"279","author":"Zhang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2025.177353_bib27","article-title":"Astragalus membranaceus injection suppresses production of interleukin-6 by activating autophagy through the AMPK-mTOR pathway in lipopolysaccharide-stimulated macrophages","volume":"2020","author":"Zhang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T23:48:14Z","timestamp":1743983294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":27,"alternative-id":["S0014299925001062"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177353","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside IV prevents liver fibrosis by blocking glycolysis-mediated macrophage M1 polarization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177353"}}